Healthy Extracts (HYEX) Operating Leases (2023 - 2026)

Healthy Extracts (HYEX) posted quarterly Operating Leases of $344265.0 for Q4 2025, up 105.24% quarter-over-quarter from $167734.0 in Q3 2025.

Healthy Extracts (HYEX) Operating Leases (2023 - 2026) Analysis & Trends

Healthy Extracts' Operating Leases history runs 3 years deep, the most recent figure standing at $344265.0 for Q4 2025.

In Q4 2025, Operating Leases changed N/A year-over-year to $344265.0; the TTM figure through Dec 2025 stood at $344265.0 (changed N/A YoY), while the FY2025 annual figure was $344265.0, changed N/A from the prior year.
Operating Leases for Q4 2025 stood at $344265.0, up from $167734.0 in the prior quarter.
The five-year high for Operating Leases was $344265.0 in Q4 2025, with the low at $9222.0 in Q4 2023.
The 3-year median for Operating Leases is $90333.5 (2024), against an average of $113852.9.
Peak annual rise in Operating Leases reached 129.75% in 2025, while the deepest fall reached 129.75% in 2025.
Healthy Extracts' Operating Leases stood at $9222.0 in 2023, then soared by 538.76% to $58906.0 in 2024, then soared by 484.43% to $344265.0 in 2025.
Business Quant data shows HYEX's Operating Leases at $344265.0 in Q4 2025, $167734.0 in Q3 2025, and $121761.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-
10	Healthy Extracts	19.90 Mn	19.71 Mn	1.45 Mn

Download Data